Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bom

Antonius Helena Adolf Bom, Newhouse GB

Patent application numberDescriptionPublished
20100075938Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block - The invention relates to the use of chemical chelators for the preparation of a medicament for the reversal of drug-induced neuromuscular block, to a kit for providing neuromuscular block and its reversal, and to cyclophane derivatives having the general formula A03-25-2010

David C. Bom, Cincinnati, OH US

Patent application numberDescriptionPublished
20090030042Amide Addition Reaction - A method of making a compound of formula II01-29-2009
20090069365Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators - The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).03-12-2009
20090163572Cooling Compounds - A method of providing a cooling sensation to the skin or the mucous membranes of the body, comprising the application thereto of at least one compound of the Formula I06-25-2009
20100190772Substituted Azepine Derivatives As Serotonin Receptor Modulators - The present invention generally relates to compounds and pharmaceutical compositions containing the compounds. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).07-29-2010

Patent applications by David C. Bom, Cincinnati, OH US

David C. Bom, Broadview Heights, OH US

Patent application numberDescriptionPublished
20080287465Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof - Acrylic n-hydroxy imides and their use in pharmaceutical compositions and in the inhibition of flap endonuclease are disclosed.11-20-2008
20110112072THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF - The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5-HT05-12-2011

Patent applications by David C. Bom, Broadview Heights, OH US

Lars Morten Bom, Herlev DK

Patent application numberDescriptionPublished
20110034878DEVICE FOR INJECTING APPORTIONED DOSES OF LIQUID DRUG - A mechanical injection device (02-10-2011
20110046565DEVICE FOR INJECTING APPORTIONED DOSES OF LIQUID DRUG - A mechanical injection device (02-24-2011

Nicolaas Bom, Berkenwoude NL

Patent application numberDescriptionPublished
20100198075INSTANTANEOUS ULTRASONIC ECHO MEASUREMENT OF BLADDER VOLUME WITH A LIMITED NUMBER OF ULTRASOUND BEAMS - An apparatus and methods to quantify the volume of urine in a human bladder with a limited number of acoustic beams is disclosed. In a first version a plurality of narrow ultrasound beams is transmitted in different directions towards the bladder. Returning echoes are converted to digital form and stored in memory. A volume display on the apparatus allows to define the optimal apposition of the transducer assembly. Signal processing software automatically determines the bladder Depth D and Height H and computes the volume of urine. In a second version, a single wide angle ultrasound beam transducer transmits ultrasounds signals at a fundamental frequency to quantify the urine volume. Return signals originating from a depth beyond the usual position of the posterior wall depth of a filled bladder are analyzed for presence of higher harmonic signals, which in turn are related to the presence or absence of urine.08-05-2010

Patent applications by Nicolaas Bom, Berkenwoude NL